Common Contracts

Ordinary Shares Vascular Biogenics Ltd. Ordinary Shares (NIS 0.01 Nominal Value) EQUITY UNDERWRITING AGREEMENT

Vascular Biogenics Ltd. • July 29th, 2014 • Pharmaceutical preparations • New York

• Company
  Vascular Biogenics Ltd.
• Filed
  July 29th, 2014
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

Vascular Biogenics Ltd., an Israeli company (the “Company”), proposes to sell to the several underwriters (the “Underwriters”) named on Schedule I hereto for whom you are acting as representatives (the “Representatives”) an aggregate of shares (the “Firm Shares”) of the Company’s ordinary shares, NIS 0.01 nominal value (the “Ordinary Shares”). The respective amounts of the Firm Shares to be so purchased by the several Underwriters are set forth opposite their names on Schedule I hereto. The Company also proposes to sell at the Underwriters’ option an aggregate of up to additional shares of the Company’s Ordinary Shares (the “Option Shares”) as set forth below.

] Shares Scorpio Bulkers Inc. Common Shares ($0.01 Par Value) FORM OF EQUITY UNDERWRITING AGREEMENT

Scorpio Bulkers Inc. • December 11th, 2013 • Deep sea foreign transportation of freight • New York

• Company
  Scorpio Bulkers Inc.
• Filed
  December 11th, 2013
• Industry
  Deep sea foreign transportation of freight
• Jurisdiction
  New York

Scorpio Bulkers Inc., a Marshall Islands corporation (the “Company”), proposes to sell to the several underwriters (the “Underwriters”) named on Schedule I hereto for whom you are acting as Representative (the “Representative”) an aggregate of [ ] shares (the “Firm Shares”) of the Company’s common shares, $[ ] par value (the “Common Shares). The respective amounts of the Firm Shares to be so purchased by the several Underwriters are set forth opposite their names on Schedule I hereto. The Company also proposes to sell at the Underwriters’ option an aggregate of up to [ ] additional shares (the “Option Shares”) as set forth below.